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Abstract
Background: Performance enhancement (PE) is a natural and essential ingredient of competitive
sport. Except for nutritional supplement contamination, accidental use of doping is highly unlikely.
It requires deliberation, planning and commitment; and is influenced by a host of protective and risk
factors.
Hypothesis: In the course of their career, athletes constantly set goals and make choices
regarding the way these goals can be achieved. The cycle of choice – goal commitment – execution –
feedback on goal attainment – goal evaluation/adjustment has numerous exit points, each providing an
opportunity for behaviour change, which may or may not be related to the use of prohibited
methods. The interplay between facilitating and inhibiting systemic and personality factors,
constantly influenced by situational factors could result in an outcome vector of 'doping attitudes',
which combines with subjective norms to influence intentions to choose prohibited PE methods.
These influences also vary from one stage of athlete development to the next, making some
athletes more vulnerable to engaging in doping practices than others, and more vulnerable at
certain time periods – and not others.
Testing the hypothesis: Model-testing requires a series of carefully planned and coordinated
studies. Correlational studies can establish relationships where the directionality is not-known or
not important. Experimental studies with the manipulation of doping expectancies and risk factors
can be used to demonstrate causality and evaluate potential intervention strategies. The final model
can be tested via a behavioural simulation, with outcomes compared to those expected from
literature precedence or used as a simulated computer game for empirical data collection.
Implications: A hypothesized life-cycle model of PE identifies vulnerability factors across the
stages of athlete development with the view of informing the design of anti-doping assessment and
intervention. The model suggests that, instead of focusing on the actual engagement in prohibited
PE practices, deterrence strategies are likely to be more effective if they target the influencing
factors at the appropriate stage and identify groups of athletes and their respective career stages,
which pose particular risks of engagement in doping practices. This enables a more effective
intervention approach by targeting specific risk factors and expectancies.
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The amateur notions of the 'gentleman sport' have been
surpassed by the need for effectiveness and efficiency in
order to maintain the constant improvement of sports
performance. Activities once unacceptable – e.g. being
coached or trained [1] – have become norms. Harold
Abrahams' gold in the 1924 Olympics 100 metres sprint
stood out for the professionalism of his preparation,
which included systematic training and hiring a coach [2],
it would be unusual not to take this course of action
today. The athlete body is now seen as a highly specialised
'tool' that is altered for maximal performance [3]. Scien-
tists constantly seek ways to improve sports performance.
In the early years of training, activities were aimed to
refine skills and perfect techniques; the paradigm shift
from fixed to expendable capacities, hence to performance
enhancement, had not occurred until the cold war era [4].
Athletes today are expected and encouraged to seek every
possible way to improve their performance, including
specialised training, hi-tech design of equipment and
apparel, scientific and medical support, including the use
of nutritional supplements [5]. Being a high performing
athlete is a profession that requires dedication, long-term
commitment and sacrifice [6].
Although there are many ways to put strain on health dur-
ing the athletic career (e.g. excess training, injuries or dis-
ordered eating), the greatest concern to sport governing
bodies is the chemical alteration of athletic performance
[7,8]. The intriguing question here is what compels ath-
letes to risk their health or reputation for outstanding
sports performance and what factors make athletes vul-
nerable to doping and at which point of their careers.
Among personality factors, low self-esteem and high trait
anxiety [9] were found to be contributing factors to dop-
ing among preadolescents, but a reversed pattern was
observed in high school athletes, where substance users
appeared to be less anxious and more self-confident than
their non-user counterparts [10].
Engagement in risky behaviours outside the sporting con-
text and using nutritional supplements have been found
to increase the likelihood of doping [9,11,12] and self-
efficacy in risky situations [12] has been linked to prohib-
ited substance use. In terms of predicting behavioural out-
come, attitude and beliefs usually correlate significantly
with doping behaviour [12,13] and in many cases, behav-
ioural intention was found to be the strongest predictor
[9,12,14]. Strelan and Boeckmann's model of hypotheti-
cal doping use posits that personal moral beliefs and
health concerns act as preventing factors, whereas drug
testing and sanctioning have little deterrent effect [15].
Interestingly, in a search for predicting factors of steroid
use, no significant difference was found in the characteris-
tics of the steroid users and those who were offered but
reportedly declined the drug [16].
Athletes' self-reported reasons for taking performance
enhancing substances are mainly related to achieving bet-
ter performance or inner desire to win [10,17-26],
improving appearance [22,25], perceived external pres-
sure [17,23,25], and fear that competitors have a chemi-
cally or medically enhanced, unfair advantage [27-29].
Painkilling drugs and other doping agents are also viewed
as a necessary means to overcome injuries [17,26,30-32].
Athletes may also use doping as a means to cope with the
extraneous physical demands of training and competition
[29]. Whilst most athletes would prefer to compete drug-
free, those who are involved in high level sport competi-
tions tend to agree that doping is a necessary add-on to
competitive sport [22]. Many athletes are inclined to use
doping provided that the drug is undetectable [31,33],
while others do not see doping as a 'problem', to them it
is a part of their normal training regime [34,35]. Availabil-
ity or access to performance enhancing drugs is perceived
by athletes as a barrier they must overcome if they are
determined to use such means [36]. A recent study among
adolescent athletes from all levels shows that almost half
of the athletes had paid for the drug whereas for approxi-
mately 10–14%, the drug was offered by a friend, parent
or family doctor [10].
The degree of rationality in doping decision making is
highly debated [37]. Economic models of doping mainly
assume that athletes act according to economic rational-
ity. The literature in this area [38-42] considers doping as
a special case of a prisoners' dilemma [43], where one
actor's action has consequence for both actors and the
best collective strategy is difficult to reach due to lack of
information on, and trust for, the other actor's decision.
To translate the dilemma into sports, athletes' best case
would be to compete at doping-free events. However, the
widespread suspicions and speculations about other ath-
letes' possible actions, coupled with the lack of informa-
tion about the others' doping behaviours have the
potential to bias most athletes in favour of doping: game-
theoretic modelling suggests that the majority of compet-
itors are likely to see doping as their best option and,
under certain circumstances, the only feasible strategy to
ensure winning [41].
Whilst economic models of doping have ignored individ-
ual dispositions toward doping when it comes to decision
making, they emphasise the importance of a broader situ-
ational context, within which decisions are not only made
on individual preferences but in consideration of others'
actions. Existing behavioural doping models have made
attempts to incorporate personality, decision making
rationality and situational context, including peer groupPage 2 of 12
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touched upon attitudes and other important factors con-
tributing to doping but with a few exceptions [13,18],
there has been little attempt at empirical model building
or testing.
The hypothetical model
The model we propose here can be characterised by i) the
combination of trait, systemic and situational factors, ii)
its developmental approach and iii) the assumed out-
come expectancy that led to functional use of PE sub-
stances by athletes. A similar approach has been proposed
in dealing with substance abuse [51]. The central premise
of the model is the dynamics of the PE expectancies. The
expectancy theory posits that a given behaviour is moti-
vated by the desire to attain an expected positive outcome
and at the same time, controlled by the expected undesir-
able outcomes from that behaviour [52]. Athletes' motiva-
tion to engage in, or refrain from prohibited PE practices
is assumed to be influenced by the magnitude and
dynamics of positive and negative expectancies and their
developmental pathways. Individual differences between
athletes and intrapersonal fluctuations across develop-
mental stages are explained by the changes in the PE
expectancy construct, which may serve as an effective
starting point for anti-doping interventions.
Our model is based on the notion that doping practices
grow out of habitual engagement in a range of acceptable
performance enhancement (PE) practices, such as physio-
therapy, advanced nutrition, training techniques, special-
ised equipment and apparel [53]. This growth is
influenced by two distinct classes of vulnerability factors,
controlled by internal and external inhibiting factors and
constantly moderated by the situational factors. The
model also recognises that drug taking behaviour does
not happen in a vacuum. Social, economic, political and
cultural environmental constituencies influence people's
choices and decisions. Such environmental factors may
include i) the legal status and easy access to performance
enhancing drugs, ii) medical and pharmacological
advancements, iii) political and economic climate, and
iv) the general attitude toward using drugs to assist with
aspects of life not necessarily require medical treatment (a
phenomenon known as medicalisation [54-56]). The
increasing medical intervention has been justified on the
grounds of the unique needs of a high performing athlete.
Athletes rely upon medical help to reach their maximum
potential, to prevent injury or shorten recovery time if
injury happened [5,57] and such intervention is not only
widely accepted but expected by all stakeholders.
The life-cycle model of doping assumes a strategic (or
functional) use [58] of performance enhancements. As
such, it has been developed for athletes who regularly par-
ticipate in organized sports competition, where the aim is
winning, being the best or setting/breaking a record. How-
ever, the life-cycle model of PE and the vulnerability fac-
tors are applicable to all sporting and non-sporting
situations where a perceived 'pill taking' shortcut or 'quick
fix' is available. For example, steroids, growth hormones,
stimulants and even diuretics have shown to be used
among health club users to improve appearance, rather
than athletic performance [59,60]. It has been docu-
mented that high school students routinely use supple-
ments and performance enhancing substances for a
variety of sport and non-sport related reasons [61,62].
Therefore, the model can be applied to all situations
where the end goal (sport performance enhancement) can
be substituted with alternative goals (enhancement of
appearance, body image, weight loss, etc.). With the
exception of diuretics and laxatives that are routinely used
as a 'quick fix' to weight problems and often in association
with eating disorders [63-67], none of these goals are real-
istically achievable without work, determination and goal
commitment. Despite the marketing claims, chemical
assistance alone does not yield sustainable results.
Influencing factors
Stages of the life cycle model of PE are affected by a host
of vulnerability and inhibiting factors, which are catego-
rised as: i) individual differences and ii) systemic factors
(Fig 1). The interplay between the relatively stable person-
ality and the arbitrary (hence temporarily stable) systemic
factors is constantly influenced by the fluid situational
and environmental factors that relate to the ever-increas-
ing pressure to win, perceived behavioural control, avail-
ability of doping and alternative PE methods, access to PE
drugs, current use of nutritional supplements and prior
experience with prohibited PE methods. Shared norms in
individuals' social group and their social capital are also
thought to play an influencing role in choices regarding
PE practices [35]. These contextual contingencies are
assumed to moderate the synergy between personality
and systemic factors and have effects on the choices ath-
letes made in their PE life-cycle.
Vulnerability factors
Investigating predicting factors, a range of psychological
variables have been linked to doping behaviours [37].
These individual difference factors include dispositional
risk taking and sensation seeking, attitude toward peers,
authority and 'fair play', self-esteem, confidence and
integrity, cognitive ability, beliefs about doping efficacy,
independence and vulnerability to peer pressure.
From athletes' perspective, doping-related risks stem from
two distinct sources. First, the current test-based deter-
rence system poses a risk of failing the doping test, which
may be further exaggerated by the governing bodiesPage 3 of 12
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measure. Second, some PE methods pose considerable
health risks to athletes. Unfortunately, under the current
anti-doping regulation, it is likely that athletes (and other
stakeholders) involved in prohibited performance
enhancement practices will place a greater emphasis on
avoiding a positive test than on avoiding health risks. In
the present punitive system, testing may be perceived by
all stakeholders as a barrier to overcome (e.g. to avoid a
positive test) and health concerns come only second to
using effective but undetectable or not-yet-prohibited (i.e.
new or experimental) methods. Anti-doping intervention
strategies are likely to be more effective if they incorporate
changes in the regulatory system that addresses both
health protection and preservation of the 'drug-free' sport
principles.
The hypothesised systemic factors include motivational
climate, authority structure and PE culture in athletic
teams and wider athletic community, as well as perceived
fairness and other attributes of the testing procedures and
enforcement sanctions. These systemic factors impact on
the individual athletes' career progression and opportuni-
ties. Competitive athletes naturally strive for achievement,
but the ways in which achievement can be accomplished
may differ considerably from one individual to another;
or from one context to another. It is safe to assume a con-
sistent level of achievement motivation in the population
covered by the model: aspiring athletes are all likely to be
high achievers [68]. The nature of athletes' achievement
striving may take two distinct forms: ego orientation or
task orientation, motivated by internalised behavioural
norms and desire for personal improvement or winning
and external comparison [69]. These orientations are
linked to self-beliefs about their own abilities being fixed
or incremental [70]. Motivational climate is critical to
forming these self-beliefs and subsequently, the task-vs-
ego orientation. Anti-doping interventions that focus on
developing mastery climate and foster task orientation in
sport-related goals are likely to reduce athletes' inclination
to use unacceptable PE methods.
Motivational climate is shaped by external achievement
expectations from coaches, parents, peers and fans, as it is
perceived by the athlete. Whether the athlete perceives the
achievement expectation from his/her environment as a
progress and constant improvement (so called 'mastery
climate') or as constant competition and desire to win
('performance climate') influences the athlete's subse-
quent choices and behaviours [71]. An emphasis on the
outcome, such as results and winning, is more likely to
lead to maladaptive motivational and affective responses
such as taking short-cuts, cheating or aggressiveness [72].
Furthermore, the PE subculture of a particular sport may
prompt athletes to take drugs in order to show solidarity
with peers, or to enhance their (athletic) identity by
engaging in doping practices which are seen by the subcul-
ture as transitional markers denoting the transition from
'amateur' to being a serious athlete [46]. Altering role
expectancies (i.e. what it means to be a high-performing,
serious athlete) are likely to be particularly effective in
interventions with adolescent athletes in sports with high
prevalence of doping.
Inhibiting factors
Factors that may avert individuals from using perform-
ance enhancing drugs are related to the current punitive-
sanctioning anti-doping system, cultural – religious
norms, moral values, social pressure from close relatives
and friends and health concerns. Some personality traits
can act as inhibitors of doping engagement (e.g. positive
and stable self-esteem, conscientiousness and low risk-
taking propensity). Intervention as a preventive factor has
been the most extensively researched aspect. Gender spe-
cific, team centred education has been shown to result in
self-reported behaviour change in the Adolescents Train-
ing and Learning to Avoid Steroids (ATLAS) [73,74] and
the Athletes Targeting Healthy Exercise and Nutrition
Alternatives (ATHENA) [74,75] but effectiveness of such
education programmes should be validated beyond self-
reports.
Athletes may also refrain from doping or using other sup-
plements if they perceive the consequences of a positive
doping test as unacceptably high. However, while a ran-
dom drug testing program (SATURN) among high school
athletes did not result in significant reduction in preva-
lence, it has increased some risk factors (reduced belief in
own athletic ability and more permissive attitude) for
The major groups of vulnerability factors in dopingFigure 1
The major groups of vulnerability factors in doping.Page 4 of 12
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inhibitor does not have any relevance to those who use
performance enhancing supplements outside sporting
arena.
Situational factors
The hypothesised situational factors include the dynamics
of peer interactions [44], salience of role models and sig-
nificant others [45] and, most importantly, the availabil-
ity of performance enhancement alternatives – both
acceptable and illegal [37]. Most of these factors have a
strong developmental aspect to them – as attitudes, role
models, vulnerability to peer pressure, performance
enhancement motivation and the ingredients of moral
choice tend to change systematically form one stage of
athlete's development to the next. This multitude of influ-
encing factors result in an outcome vector called 'doping
attitudes', which, according to the Theory of Reasoned
Action [77] and Theory of Planned Behaviour [78], com-
bine with subjective norms to influence intentions to
choose doping at one stage of the PE life-cycle. The
dynamics of this process is demonstrated in the life-cycle
model of PE (Fig 2). Transition points providing opportu-
nities for interaction are therefore to be expected, with
some of these factors gaining – and others loosing – their
salience and impact. Exploiting the interactions between
personality traits, behavioural tendencies and doping
expectancies is likely to improve the effectiveness of inter-
vention and deterrence strategies. For instance, research in
substance abuse shows that expectancies have a greater
influence on impulsive than non-impulsive individuals
[51].
Environmental factors
Environmental factors include the socio-cultural, political
milieu, the legislative system, as well as the availability of
drugs, new drug discoveries and permitted alternatives,
such as nutritional supplements, minerals, herbs and
non-herb non-mineral substances. The importance placed
on sporting success in a society and the direct and indirect
reward for such success influence the motivational climate
in which athletes prepare and compete. Criminalisation
or decriminalisation of the PE drugs may only have an
effect on the level of use via the distribution mechanism.
Studies show that decriminalisation of social drugs do not
have the effect on the prevalence rate [79,80]. The situa-
tion with PE drugs is more complicated as the array of PE
practices includes drugs and methods that require medical
assistance and freely available supplements that may or
may not be on the Prohibited List but have similar ergo-
genic properties to the prohibited drugs [81,82]. The
widespread medicalisation of life creates an environment
in which using medical or chemical assistance to life is
widely accepted and normal. Many athletes believe that
they need assistance in order to cope with the physical
demand of training, workload, injury and recovery. Under
the current anti-doping regulation, athletes may turn to
PE methods and substances that are not included in the
Prohibited List in order to: i) eliminate the risk of being
caught, ii) play by the rules or iii) conform to the ethical
or moral principles imposed on them by their social envi-
ronment. However, the potentially negative impact on
health [83,84] should be of particular interest as the
health risks associated with nutritional supplements are
often overlooked or minimised. The proposed alternative
testing methods (i.e. biological passport or health pass-
port) where the ergogenic effects or unexplained changes
Life cycle model of performance enhancementFigure 2
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of certain drugs in the body may address this gap, hence
the effect of these proposed regulatory changes should
also be considered among the environmental factors.
The life-cycle model of performance enhancement
The use of performance enhancing methods is unlikely to
be an accident. It requires sustained, self-regulated, goal-
directed effort [85,86]. Doping use is assumed to exhibit
similar characteristics to 'functional drug use' which has
been recognised as a specific from of drug use [87,88].
Functional drug use is distinct from experimental, recrea-
tional or dependent use (abuse/addiction) and it refers to
a strategic use of substance to achieve a set goal (i.e.
improve a function or skill). Examples for functional use
include but are not limited to using stimulants to increase
alertness or balance long working hours; or taking hyp-
nosedatives to help coping with anxiety, stress or depres-
sion [58]. Functional drug use is not necessarily
problematic in the sense of addiction although physical
and psychological dependence may develop from func-
tional use. Athletes' reasons for taking performance
enhancing substances (as discussed earlier) are in keeping
with the definition of functional drug use. One of the
main advantages of the life-cycle model over the tradition-
ally used trait or situational models is that the develop-
mental nature of the proposed model offers various
intervention points and suggests a varying set of methods
to match those points. These intervention strategies are
discussed in detail along with the description of the life-
cycle model of performance enhancement and can be
summarised as follows: Chronologically, the first inter-
vention points focus on the risk factors by preventing the
onset of risks or transforming risks that are already
present. Whilst these options are considered less effective
in substance abuse [51], the unique nature of perform-
ance enhancing substance use offers scope for interven-
tion at this stage by changing not the athlete but the
environment that influences the onset of doping use.
With that in view, the responsibility for deterrence is
broadened from individual athletes to the inter-related
system of rules, regulations, expectations by coaches, sup-
port personnel and policy makers. An intervention
approach that aims to alter expectancy trajectories or
modify current maladaptive expectancies (e.g. in relation
to steroid use which is prone to developing physiological
and psychological dependence) is likely to produce more
lasting effects. Based on research on substance abuse [51],
it is envisaged that preventing the development of positive
doping expectancies before the onset of a doping-related
event may work well with pre-adolescents, whereas ath-
letes with doping experience or in positions to seriously
contemplate the use of prohibited PE methods may
respond better to modifications of expectancy pathways,
especially if comparable and acceptable alternatives are
offered.
Our model is based on the existing models of self-regula-
tion containing a number of stages by which athletes
engage in performance enhancing practices. These include
the phases of: i) choice, ii) goal commitment, iii) execu-
tion, iv) goal attainment feedback, v) goal evaluation and
adjustment and vi) decision to continue (start the next
cycle) or exit. Each phase of the cycle has its risks and vul-
nerabilities. They contain breaking points that can be
exploited by a carefully designed anti-doping intervention
(Table 1).
Choice
The cycle starts with an entry point during the athlete's
career when specific (typically short to mid term) per-
formance target is set, either by the athlete or their coach,
and a means of performance enhancement is chosen to
service that target. The key question of this phase is: 'What
is the end you want to achieve?' The range of motives for
engaging in coordinated performance enhancing practices
can be classified into one of the three main types. First,
there is the achievement motivation, the drive to get
ahead of others in the sense of winning and record break-
ing aspirations. Second, there are affiliation motives that
are based on the need to be liked and lead to seeking fame
and popularity. Finally, intrinsic motivation leads are
Table 1: Vulnerability factors and potential individual and systemic remedies
Potential remedies
Vulnerability Individual (therapy style, one on one 
intervention)
Systemic (system level adjustment)
Compulsiveness Perspective taking, balanced life goals Athletes as a person, not result-generating device
Single mindedness Self-esteem work: winner vs. worthwhile, self-
respecting person
Career transition (i.e. life after sport)
Risk aversion Communicate the risk: health, legal, financial, social, 
psychological
Support independent research re toxicity of PE methods to 
established standard
Expediency Value system, collaborative work Replace prohibition with mandatory informed consent and 
supervision Incentives for fair playPage 6 of 12
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itself, i.e. from high intensity training. The choice out-
comes of this phase are likely to be influenced by the com-
bination of i) costs (including time and effort) and
availability of the method(s), and ii) personality factors,
such as compulsiveness or single mindedness [44]. The
potential intervention at the individual level might
involve teaching perspective taking, multiple goal setting
and developing a broader perspective on life beyond
sport. These intervention strategies can (and should) be
complemented by compelling other stakeholders, such as
parents, coaches, sport organisations, society and media
to support and encourage the athletes' broader goals.
Doping expectancy alterations can be achieved by modi-
fying associations with positive outcomes, e.g., by provid-
ing healthier and more acceptable alternatives while
reinforcing the negative associations of doping with
health consequences.
Goal commitment
Achieving the gains of performance enhancement requires
considerable commitment and hard work from the ath-
lete. PE objectives cannot be achieved on a whim. They
require sustained effort and self-discipline over a consid-
erable period of time. The key question of this stage is:
'How badly do you want it?' A strong goal commitment
becomes a necessary entry requirement at this stage of the
life-cycle model of PE. It may flow naturally and implicitly
from the athlete's passion for their sport based on any
combination of achievement, affiliation or intrinsic
motives described above. It may also take the form of
'conscious assembly of reasons' when athletes deliberately
search for additional sources of motivation [89]. Interven-
tions may emphasize the scope and complexity of the
undertaking, as well as prompting broader motives for
consideration at the 'motivational build-up' stage.
Execution
Performance enhancement only provides a time-shortcut.
The gains from investment in PE methods depend on the
increased density and intensity of training regime. This
may also require adherence to new, more complex train-
ing regimes to be effective. The key intervention question
of this phase is:'Do you know what is involved and are you
prepared for the hard work?' Following through and execut-
ing the intention becomes a distinct challenge. In addi-
tion to strong commitment, knowledge and discipline are
required to meet this challenge. Support from training
and medical personnel and family is likely to play an
important role in execution, therefore anti-doping deter-
rence should incorporate these supporting roles as well.
Educating and changing expectancies of family and sup-
port personnel has the potential to alter the likelihood of
the successful execution of the PE cycle.
Goal attainment feedback
During the feedback stage, achieved results are compared
to the set achievement goals in order to assess whether the
chosen PE method delivered its promises. At this stage,
doping expectancies are either confirmed or refuted. Dis-
crepancies between goals and achievements are scruti-
nised to identify inhibiting factors (i.e. flaws in
implementation or falling for false promises). Costs and
alternative methods are also considered. The key question
at this stage is: 'Have you got what you had hoped for?'
Goal evaluation and adjustment
Sustained self-regulation assumes continuous re-evalua-
tion of goals. Any incongruence between goals and
achieved results is examined at with the intention of iden-
tifying hindering or facilitating factors and contingencies.
The key question at this stage is: 'Has your PE plan worked?'
Conclusions from this stage determine the decision
regarding the next stage of the PE life-cycle. This stage
offers a good opportunity for anti-doping intervention
targeting doping expectancies. Athletes at this stage may
have already experienced side effects. It is also plausible
that the PE regime worked in terms of improved sports
performance but failed to yield the ultimate prize of win-
ning or gaining the expected rewards. Intervention strate-
gies at this stage should provide acceptable and
comparable alternatives to prohibited PE methods. Ath-
letes who are not entirely satisfied with their chosen PE
regime are likely to be open to modification of doping
expectancies.
Entry vs. exit of the cycle
The key question of this stage is: 'What is next?' The out-
comes of the goal attainment and the goal evaluation
stages lead to one of the three possible outcomes: i)
repeating the cycle without changes, ii) repeating the cycle
with modification, and iii) abandon the effort of perform-
ance enhancement.
Summary of the life-cycle model
There is no reason to expect fundamental differences in
the cognitive or motivational process involved in the ath-
lete's decision cycle whether it deals with acceptable PE or
doping methods [90]. Hence, the model of PE presented
above does not make a distinction between accepted and
prohibited means of PE. Both need a sustained, moti-
vated, goal-directed action. The difference is brought
about by the current convention of the sport, in particular
whether or not the method is deemed to be acceptable or
unacceptable in it.
Testing the hypothesis
Considering the complexity and reiterative nature of the
model, empirical testing of the model as a whole is not
feasible. Hence it is proposed that the robustness of thePage 7 of 12
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where the behavioural outcomes are compared to those
expected from literature precedence or prior empirical
studies. Decisions made in hypothetical situations have
been shown to be predictive of relevant behaviour [15].
Proposed Approach
In order to set the parameters of the model, knowledge
can be accumulated via a thorough literature search where
scientific evidence is available for i) drug efficacy, detecta-
bility and toxicity, ii) comorbidity of drug and doping
[91-94]; nutritional supplements and anabolic steroids or
other doping [11,90,95], as well as iii) relevant personal-
ity factors and their influence on behavioural outcomes
[12,14,15,49,50].
A series of independent studies should aim at gaining
empirical evidence regarding the influence of each identi-
fied factor on the respective elements of the model. Corre-
lational studies can establish relationships where the
directionality is not known or of no importance. Experi-
mental studies with the manipulation of doping expectan-
cies and risk factors can be used to examine causality and
evaluate potential intervention strategies. Specifically,
empirical research contributing to the model parameters
could be conducted in one or a combination of the fol-
lowing areas:
i) Experimenting with and developing reliable methods
for collecting information on or estimate the prevalence
of doping behaviour (i.e. implicit assessment or estima-
tion);
ii) Identifying internal risk and protective factors;
a. personality factors that are linked to doping behaviour
(e.g. achievement orientation, self-belief, self-esteem, self-
efficacy, trait anxiety, risk taking/aversion, etc.);
b. relationship between explicit and implicit attitude and
investigating their effect on behaviour/decision making;
c. moral value and belief system, knowledge and health
beliefs;
iii) Identifying external risk and protective factors;
a. environment effect (e.g. socioeconomic variables, type
of sport, motivational climate, etc.)
b. influence of close others (e.g. family, coach, peers, doc-
tors, etc.);
c. effect of the current and alternative anti-doping system
(e.g. punitive-sanctioning vs. permissive-controlling) on
decisions regarding doping use;
iv) Establishing the likelihood of/odds ratio for using
doping from various situational factors (e.g. nutritional
supplement use, type of sport, vested interest, opponents'
known or perceived actions, etc.)
Results from the independent studies can be combined
into the life-cycle model of performance enhancement,
which can be tested via researcher-led simulations by run-
ning series of hypothetical scenarios with different combi-
nations of personality, systemic, situational and
environmental factors. The model can also be used for
empirical testing, with being presented as a computerised
strategy game to athlete participants. The ultimate goal of
the game would be to maximise achievement within a
given timeframe.
One of its key advantages of measuring complex cognitive
functioning through synthetic environments and simula-
tions is that it is indirect, unobtrusive and entertaining.
The potential of computer game-embedded measurement
methodology in the assessment of personality and social
behaviour is in its capacity to minimise self-presentation
effects in the assessment of individual choice in contexts
of potential inter- and intra-personal conflict [96,97]. The
value of such an approach is re-affirmed by the prospects
of psychological testing in virtual reality where interper-
sonal interaction is cited among the most immediate and
attractive assessment targets [98]. Systematic observation
of player response to simulated environments in synthetic
but realistic performance enhancement scenarios has the
capacity to take the measurement of intended doping-
related behaviour beyond the inevitable distortions of
self-report methodology – whether these distortions are
intentional or not. Such observations alleviate the limita-
tions of the experimental models, while retaining the
advantage of being safe and controlled.
The impact of systemic factors on intention formation can
be examined both directly and in interaction with relevant
personality factors (i.e. risk aversion and expediency)
within experimental research frameworks. Athletes can be
presented with an option to take a new drug in a hypo-
thetical situation and asked to rate their intention to use.
Risk aversion would be expected to interact with toxicity
and expedience with detectability in predicting the
strength of implementation intention. Similar predictions
can be made for other phases of the model. Drug detecta-
bility, availability, efficacy and toxicity can be manipu-
lated in a between-subject design, where respondents
belong to one of the known 'personality' groups (i.e. goal/
task oriented, risk aversive/risk taker). Hypothetical sce-Page 8 of 12
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prevention such as the 'white list' (legalised performance
enhancing substances), biological or health passports to
investigate the likelihood of their inhibiting effect.
Whether different moral and ethical values are applied to
different situation on and off the sporting field may also
merit future investigation in order to establish the pres-
ence or absence of a 'carry over effect' between sport
(bounded by rules and aimed at scarce resources) and
other spheres of athletes' lives. This 'carry over effect' may
also be an important aspect of performance enhancing
drug use by a non-athlete population.
A relationship between social drug use and doping has
been shown in most relevant studies [10,99-101] suggest-
ing that the use of social drugs increases the chance for
doping and vice versa. However as most of these studies
used self-reported information, such claim should be
interpreted with caution and the phenomenon should be
investigated further by using alternative methods. For
example, self-report data on taking performance enhance-
ments using Random Response Technique (RRT) yield a
considerably higher percentage of athletes admitting dop-
ing than direct anonymous self-reports did [102,103].
Underscoring the fundamental shift from individual char-
acteristics of a performance enhancing drug user to peer
influences, the social network approach has been success-
fully applied in research regarding substance use and
designing, implementing and evaluating effective preven-
tion programmes [35,104]. Individual drug use (or non-
use) is strongly associated with the same behaviour in the
immediate social circle. Therefore, network level charac-
teristics such as density or centrality might be used as a
predictive or inhibiting factor in substance use [104].
Implications
The current anti-doping policy has received much criti-
cism for its elite focus, sanction-based approach and asso-
ciated costs [53,105-108]. However, the growing number
of educational programmes are designed and imple-
mented by the sport governing bodies to target varying
groups from top performing athletes to young talents
focus on the principles of performance enhancement and
fair play.
In contrast, the model presented here focuses on vulnera-
bility factors across the stages of athlete development ena-
bles us to i) develop empirically testable developmental
hypotheses and ii) examine the moderating impact of
subjective norms and motivational climate on athletes'
intentions to engage in doping. The simultaneous consid-
eration of risk factors (facilitators) and protective factors
(inhibitors) is a generally accepted approach in dealing
with delinquent behaviour, such as drug use, drinking,
violence or crime [109]. Establishing a sport-specific set of
facilitators and inhibitors (and their interaction) is pivotal
to anti-doping prevention. Whether the elimination of
performance enhancing drugs or harm-reduction is the
intended outcome, the conundrum of performance
enhancement must be overcome before meaningful pre-
vention strategies can be designed and implemented. The
proposed model offers a framework for a promising
deconvolution approach to doping as well as for perform-
ance enhancing drug use prevention in the non-athlete
population.
The model may be used as a framework for the design of
anti-doping assessment and intervention methods.
Instead of focusing on the doping attitude (outcome of
the combination of the vulnerability factors), the model
encourages an alternative of proactive consideration. In
preference to the costly and challenging detection-based
approach [108,110], which sanctions and penalises indi-
vidual athletes if the presence of the drug in their system
(regardless of the effect) is indicated or with evidence of
involvement in doping practice; we suggest targeting the
influencing factors that lead to doping. A holistic
approach with the emphasis on choices, health issues and
broader life goals to the individual and the systemic fac-
tors is needed in order for athletes to make informed deci-
sions about their performance enhancement, which may
lead – at the population level – to a sustainable change in
doping behaviour. Overall, anti-doping interventions are
likely to benefit from a dual focus on the risk factors and
doping expectancies, as well as from targeting the athlete
population from preadolescents to adults at all stages of
PE life-cycle.
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